Article
Identification of ADME genes polymorphic variants linked to trastuzumab-induced cardiotoxicity in breast cancer patients: Case series of mono-institutional experience.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie - 1 May 2024
Staropoli Nicoletta, Scionti Francesca, Farenza Valentina, Falcone Federica, Luciano Francesco, Renne Maria, Di Martino Maria Teresa, Ciliberto Domenico, Tedesco Ludovica, Crispino Antonella, Labanca Caterina, Cucè Maria, Esposito Stefania, Agapito Giuseppe, Cannataro Mario, Tassone Pierfrancesco, Tagliaferri Pierosandro, Arbitrio Mariamena
Abstract excerpt
BACKGROUND: Long-term survival induced by anticancer treatments discloses emerging frailty among breast cancer (BC) survivors. Trastuzumab-induced cardiotoxicity (TIC) is reported in at least 5% of HER2+BC patients. However, TIC mechanism remains unclear and predictive genetic biomarkers are still lacking. Interaction between systemic inflammation, cytokine release and ADME genes in cancer patients might...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
